Panacea arm defaults; lenders may extend repayment date

November 17, 2021
Panacea Biotec Pharma, a 100% subsidiary of Sputnik V Covid jab manufacturer Panacea Biotec, defaulted on payment of ₹114.67 crore including an interest component due on September 30.


via Economictimes

Post a Comment

No comments

Subscribe to: Post Comments ( Atom )